CXCL8 and arthritic joint disease: Fenofibrate, a PPAR-alpha ligand, has been shown to inhibit the development of arthritis in a rat model of human RA by reducing cytokine production (IL-6, IL-8 and granulocyte monocyte colony-stimulating factor) from FLS (107).